Government Investment Pays Off: Cue Health Gets EUA For At-Home OTC COVID-19 Test

After the US government invested almost half a billion dollars to ensure Cue Health could scale up production, the FDA announced the self-administered test will now be available over the counter.

Cue Health's COVID-19 OTC molecular test has been approved at home.

More from Regulation

More from Policy & Regulation